Persistence Market Research Projects Market Growth on Home Infusion TherapySeptember 10, 2014
September 10, 2014
Global research solutions specialist Persistence Market Research released the “Global Market Study on Home Infusion Therapy: Needless Connectors to Witness Highest Growth by 2020.” According to the report, the home infusion therapy market is projected to hit up to $26.7 billion in 2020, an upsurge from this year’s market worth $15.9 billion.
Home infusion therapy is an ideal alternative to inpatient care that eliminates the costs and efforts associated with hospital admission when frequent fluid administration and intravenous medication is required. This emerging infusion therapy technique has also been proven safe and effective to administer in the comfort and convenience of homes or alternate-site settings coined as “home infusion therapy pharmacies”.
Depending on the severity of disease and patient condition, more and more patients have preferred home infusion therapy treatment or nearby state-licensed ambulatory infusion suites. Either way, this kind of therapy requires clinical-grade infusion pump equipment, physician-prescribed IV medication, and a qualified clinician to facilitate the outpatient care.
The report further discussed that the increasing demand for home infusion therapy and advanced intravenous (IV) pump systems for pain management has been driven by the growing population rate of seniors along with the emergence of various chronic diseases, particularly in North America, Germany, China, and Japan.
On the contrary, patient safety issues associated with revolutionary infusion pump systems are considered as a hindrance to the continued growth of today’s home infusion therapy market. However, the major trends in the market such as the growing acceptance of use of infusion therapy and ambulatory IV pump equipment have countered these issues as these innovations help optimize the drug delivery and medical care.
Major medical device manufacturers and healthcare technology innovators including Baxter, B. Braun Melsungen AG, Caesarea Medical Electronics, Fresenius Kabi AG, and Smiths Medical remain dedicated to introducing product innovations that suit the home infusion therapy market.
Safety and efficacy in home infusion therapy and IV pump technology are paramount in the health care arena. Recognizing the demand to meet the medical device safety requirements of today’s healthcare facilities, AIV offers high quality refurbished IV pumps, replacement parts, accessories and repair solutions for Baxter, Smiths Medical, B. Braun, and other leading infusion pump system manufacturers.
Learn more about AIV’s full spectrum of infusion pump products and services at www.aiv-inc.com/iv-infusion-pump-replacement-parts.html today.
About the Author
AIV CatalogRequest Your Printed or Electronic Copy Today!
Be Part of Our
Healthcare technology management professionals are a vital link in hospital operations, and we proudly support the national, state, and local associations with ongoing support and resources.Get Biomed Resources
Why buy from AIV
AIV strives to provide you cost effective options to service equipment. We offer flexible solutions to best suit your needs.